Humana Announces New Value-Based Contracting Program
n the latest sign that private payers are moving compensation into value-based contracting, Humana announced four participants in its new Hospital Incentive Program (HIP).
n the latest sign that private payers are moving compensation into value-based contracting, Humana announced four participants in its new Hospital Incentive Program (HIP).
The Health Care Transformation Task Force, a 41-member group that includes some of the nation's top health systems and payers, revealed Dec. 18 that members have made substantial progress toward transitioning to value-based payment arrangements.
CMS issued a proposed rule Nov. 26 that would allow insurers to implement broader use of step therapies or drop coverage of certain protected classes of drugs if price increases outpace inflation. Below is a breakdown of the winners and losers under the proposed rule changes.
UnitedHealthcare introduced a new program Oct. 29 that incentivizes members to choose less expensive prescription drugs.
A recent investigation by the U.S. Office of Inspector General found between 2014 and 2016, Medicare Advantage organizations overturned 75 percent of their preauthorization and payment denials upon appeal.
Although 47 percent of physicians' compensation is tied to quality or value, only 18 percent of physicians say these payment will improve care or cut costs, a report from Merritt Hawkins found.
Amid a shortage, drug prices increase at roughly twice their usual rate, suggesting that pharma companies may be exploiting drug shortages to increase profits, according to a new study published in the Annals of Internal Medicine.
Drugmakers increased the price of 60 products August — a sharp decline from July, which saw 110 price increases, according to a Wells Fargo drug-pricing report.
Sixty-four percent of consumers reported that they would jump on an opportunity to prepay for medications to receive a discounted price, according to a survey from DrFirst, a provider of e-prescribing and patient medication management solutions.
The Medicare hospice program is valuable to beneficiaries at the end of life, but it's also vulnerable to fraud and poor care, according to a recent report from HHS' Office of Inspector General. The report examined vulnerabilities of the program and provided recommendations for combating them.